Dayanara Torres and Coolibar Spotlight Sun Safety and Skin Cancer Awareness Coolibar, the global leader in UPF 50+ sun protection apparel, is strengthening its commitment to skin cancer awareness through an ongoing partnership with former Miss Universe, skin cancer survivor,…
PACS Group to Announce First Quarter 2026 Financial Results on May 11 one of the largest post-acute healthcare providers in the United States, has announced plans to release its financial results for the first quarter of 2026 on Monday, May…
Veradigm Launches Real-Time Health Network Platform for Independent Practices Veradigm has introduced its new Veradigm Health Network Architecture™, a platform designed to help independent healthcare practices gain access to the kind of real-time operational, clinical, and financial insights that have…
Definitive Healthcare Reports Solid Q1 2026 Results with Revenue at High End of Guidance Definitive Healthcare, a leading provider of healthcare commercial intelligence and analytics, announced its financial results for the first quarter ended March 31, 2026, highlighting revenue performance…
RHÖN-KLINIKUM AG Reports Stable Q1 2026 Performance Amid Healthcare Reform Changes RHÖN-KLINIKUM AG began the 2026 financial year with stable operational and financial performance as the healthcare provider continued expanding both inpatient and outpatient care structures across its hospital network.…
AMN Healthcare Reports Strong Q1 2026 Results with Revenue Doubling Year Over Year AMN Healthcare announced financial results for the first quarter of 2026, delivering significant year-over-year growth in revenue and profitability as demand for healthcare workforce solutions remained strong…
How Johnson & Johnson Uses Real-World Evidence to Accelerate Clinical Research Johnson & Johnson (J&J) is transforming the future of medical technology development by using real-world data (RWD) and real-world evidence (RWE) to improve clinical research, strengthen regulatory submissions and…
Charles River Laboratories Reports Mixed First-Quarter 2026 Results While Reaffirming Full-Year Outlook Charles River Laboratories reported first-quarter 2026 revenue of $995.8 million, reflecting a 1.2% increase compared with $984.2 million in the same quarter last year. Despite posting a GAAP…
Brellium Strengthens Compliance Strategy With Addition of Former Medicaid Chief Medical Officer Dr. Andrey Ostrovsky Brellium, a healthcare compliance platform used by more than 200 healthcare organizations across the United States, has announced the appointment of Dr. Andrey Ostrovsky, MD,…
Delcath Shares New Real-World Findings From European Investigators Delcath Systems an interventional oncology company dedicated to advancing treatments for primary and metastatic liver cancers, announced the presentation of new clinical findings involving percutaneous hepatic perfusion with melphalan (M-PHP) using the…
Parabilis Medicines Appoints Alan M. Sebulsky to Board of Directors Parabilis Medicines, a clinical-stage biopharmaceutical company focused on developing innovative therapies through its proprietary Helicon™ peptide platform, has announced the appointment of veteran biopharmaceutical finance executive Alan M. Sebulsky to…
Healthcare Realty Announces Pricing of Upsized $600 Million Exchangeable Senior Notes Offering Healthcare Realty Trust Incorporated (“Healthcare Realty”) today announced that its operating partnership, Healthcare Realty Holdings, L.P. (“Healthcare Realty L.P.”), priced its offering of $600,000,000 aggregate principal amount of…